Type
Internal restructuring
Country
Germany
Region
Rheinland-Pfalz; Rheinhessen-Pfalz; Ludwigshafen am Rhein
Location of affected unit(s)
Ludwigshafen
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

200 jobs
Number of planned job losses
Job loss
Announcement Date
13 May 2014
Employment effect (start)
13 May 2014
Foreseen end date
31 December 2016

Description

US-American pharmaceutical company AbbVie is to cut 200 jobs until 2016 at its site in Ludwigshafen, Germany. As reported, the restructuring is to affect the production sector where 600 people are employed. Job cuts are due to ending contracts for several productions and a low production volume of two HIV drugs. 65 people shall leave the company voluntarily this year.

The president of the works' council was surprised by the amount of the job losses, but a spokesman of the company assured that they are to be implemented in a socially acceptable manner avoiding operational dismissals.


Sources

  • 13 May 2014: SWR.DE
  • 13 May 2014: Mannheimer Morgen

Citation

Eurofound (2014), AbbVie, Internal restructuring in Germany, factsheet number 77023, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/77023.